AU2021360905B2 - Controlled release fill compositions and capsules containing same - Google Patents

Controlled release fill compositions and capsules containing same

Info

Publication number
AU2021360905B2
AU2021360905B2 AU2021360905A AU2021360905A AU2021360905B2 AU 2021360905 B2 AU2021360905 B2 AU 2021360905B2 AU 2021360905 A AU2021360905 A AU 2021360905A AU 2021360905 A AU2021360905 A AU 2021360905A AU 2021360905 B2 AU2021360905 B2 AU 2021360905B2
Authority
AU
Australia
Prior art keywords
fill composition
capsule
controlled release
daltons
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2021360905A
Other languages
English (en)
Other versions
AU2021360905A1 (en
AU2021360905A9 (en
Inventor
Qi Fang
Karunakar Sukuru
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RP Scherer Technologies LLC
Original Assignee
RP Scherer Technologies LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by RP Scherer Technologies LLC filed Critical RP Scherer Technologies LLC
Publication of AU2021360905A1 publication Critical patent/AU2021360905A1/en
Publication of AU2021360905A9 publication Critical patent/AU2021360905A9/en
Application granted granted Critical
Publication of AU2021360905B2 publication Critical patent/AU2021360905B2/en
Priority to AU2026201700A priority Critical patent/AU2026201700A1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4833—Encapsulating processes; Filling of capsules

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2021360905A 2020-10-16 2021-10-14 Controlled release fill compositions and capsules containing same Active AU2021360905B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2026201700A AU2026201700A1 (en) 2020-10-16 2026-03-05 Controlled release fill compositions and capsules containing same

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063092679P 2020-10-16 2020-10-16
US63/092,679 2020-10-16
PCT/US2021/054991 WO2022081848A1 (en) 2020-10-16 2021-10-14 Controlled release fill compositions and capsules containing same

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2026201700A Division AU2026201700A1 (en) 2020-10-16 2026-03-05 Controlled release fill compositions and capsules containing same

Publications (3)

Publication Number Publication Date
AU2021360905A1 AU2021360905A1 (en) 2023-06-01
AU2021360905A9 AU2021360905A9 (en) 2024-10-10
AU2021360905B2 true AU2021360905B2 (en) 2026-01-08

Family

ID=81209315

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2021360905A Active AU2021360905B2 (en) 2020-10-16 2021-10-14 Controlled release fill compositions and capsules containing same
AU2026201700A Pending AU2026201700A1 (en) 2020-10-16 2026-03-05 Controlled release fill compositions and capsules containing same

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2026201700A Pending AU2026201700A1 (en) 2020-10-16 2026-03-05 Controlled release fill compositions and capsules containing same

Country Status (14)

Country Link
US (1) US20230372252A1 (enExample)
EP (1) EP4228608A4 (enExample)
JP (1) JP2023545494A (enExample)
KR (1) KR20230088730A (enExample)
CN (1) CN116367864A (enExample)
AR (1) AR123800A1 (enExample)
AU (2) AU2021360905B2 (enExample)
CA (1) CA3195386A1 (enExample)
CO (1) CO2023005368A2 (enExample)
IL (1) IL301692A (enExample)
MX (1) MX2023004441A (enExample)
NZ (1) NZ799086A (enExample)
TW (1) TW202228655A (enExample)
WO (1) WO2022081848A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20240099982A1 (en) * 2022-09-27 2024-03-28 Gaia Herbs Cellulose derivative free capsule for herbal extracts

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007131357A1 (en) * 2006-05-12 2007-11-22 Isa Odidi Pharmaceutical composition having reduced abuse potential
WO2020068510A1 (en) * 2018-09-25 2020-04-02 SpecGx LLC Abuse deterrent immediate release capsule dosage forms

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2627292C (en) * 2005-10-26 2012-04-17 Banner Pharmacaps, Inc. Hydrophilic vehicle-based dual controlled release matrix system
PE20141171A1 (es) * 2011-10-06 2014-09-21 Gruenenthal Chemie Forma de dosificacion farmaceutica oral resistente a alteracion comprendiendo agonista opioide y antagonista opioide
US20150366814A1 (en) * 2014-06-23 2015-12-24 Banner Life Sciences Llc All-natural enteric soft capsules comprising active ingredients
WO2016140933A2 (en) * 2015-03-02 2016-09-09 Bionpharma Healthcare Llc Immediate release soluble ibuprofen compositions
EP3285746A1 (en) * 2015-04-24 2018-02-28 Grünenthal GmbH Tamper-resistant fixed dose combination providing fast release of two drugs from particles and a powder
WO2016170097A1 (en) * 2015-04-24 2016-10-27 Grünenthal GmbH Tamper-resistant dosage form with immediate release and resistance against solvent extraction
US9943513B1 (en) * 2015-10-07 2018-04-17 Banner Life Sciences Llc Opioid abuse deterrent dosage forms

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007131357A1 (en) * 2006-05-12 2007-11-22 Isa Odidi Pharmaceutical composition having reduced abuse potential
WO2020068510A1 (en) * 2018-09-25 2020-04-02 SpecGx LLC Abuse deterrent immediate release capsule dosage forms

Also Published As

Publication number Publication date
AU2026201700A1 (en) 2026-03-26
EP4228608A1 (en) 2023-08-23
TW202228655A (zh) 2022-08-01
AU2021360905A1 (en) 2023-06-01
KR20230088730A (ko) 2023-06-20
JP2023545494A (ja) 2023-10-30
NZ799086A (en) 2026-02-27
MX2023004441A (es) 2023-05-08
AR123800A1 (es) 2023-01-11
WO2022081848A1 (en) 2022-04-21
CO2023005368A2 (es) 2023-05-19
CN116367864A (zh) 2023-06-30
CA3195386A1 (en) 2022-04-21
AU2021360905A9 (en) 2024-10-10
IL301692A (en) 2023-05-01
EP4228608A4 (en) 2024-10-02
US20230372252A1 (en) 2023-11-23

Similar Documents

Publication Publication Date Title
US12133922B2 (en) Abuse resistant capsule
AU2026201700A1 (en) Controlled release fill compositions and capsules containing same
US20230390210A1 (en) Modified release softgel capsules
HK40090240A (zh) 控释填料组合物和含有该组合物的胶囊
HK40049427A (en) Abuse resistant capsule
HK40004515A (en) Abuse resistant capsule
HK40004515B (en) Abuse resistant capsule

Legal Events

Date Code Title Description
SREP Specification republished